ABSTRACT:
Pilocarpine, a muscarinic receptor agonist, is clinically used to reduce intraocular pressure via ciliary muscle contraction. However, the intracellular signaling pathways mediating pilocarpine‐induced nitric oxide (
NO
) and prostaglandin E
2
(
PGE
2
) synthesis in the ciliary muscle are not fully understood. This study aimed to characterize the muscarinic receptor subtypes and intracellular mechanisms involved in pilocarpine‐induced
NO
and
PGE
2
production in porcine ciliary muscle and to explore the potential implications of these pathways in age‐related ocular changes, including presbyopia. Ciliary muscle strips from adult porcine eyes were incubated in Krebs‐Ringer buffer with pharmacological agents. Nitrate levels were measured using a Griess reaction‐based colorimetric assay, and
PGE
2
concentrations were quantified via
ELISA
. Selective receptor antagonists and enzyme inhibitors were used to investigate receptor involvement and signaling cascades. Statistical significance was determined using unpaired
t
‐tests (
p
< 0.05). Pilocarpine elicited a concentration‐dependent increase in nitrate and
PGE
2
production, peaking at 1 × 10
−7
M. This effect was inhibited by atropine, pirenzepine (
M
1
antagonist), and
J104129
(
M
3
antagonist), but not by the
M
2
antagonist
AFDX
116. Inhibitors of nitric oxide synthase (L‐
NMMA
, L‐
NIO
), phospholipase C (U‐73122), cyclooxygenase (diclofenac), and calcium signaling (verapamil,
TFP
) all reduced mediator production, while calcium ionophore
A23187
enhanced it. Pilocarpine activates
M
1
and
M
3
muscarinic receptors in the porcine ciliary muscle, stimulating
NO
and
PGE2
production via calcium‐dependent
PLC
–
NOS
–
COX
signaling. These pathways may influence ciliary muscle function and lens physiology, offering potential therapeutic targets for glaucoma and presbyopia.